see
major
articl
byington
et
al
page
issu
clinic
infecti
diseas
byington
et
al
report
find
biglov
better
identif
germ
longitudin
viral
epidemiolog
studi
base
serial
molecular
test
respiratori
virus
carri
defin
popul
biglov
provid
wealth
inform
relationship
respiratori
symptom
respiratori
viral
infect
studi
stand
squar
tradit
histor
communitybas
studi
viral
respiratori
infect
includ
cleveland
famili
studi
tecumseh
studi
new
york
seattl
viru
watch
studi
base
viral
cultur
andor
serolog
establish
current
conceptu
framework
commun
epidemiolog
viral
respiratori
tract
infect
biglov
one
new
gener
communitybas
studi
flesh
framework
use
molecular
method
sensit
previou
method
biglov
resembl
classic
studi
commun
base
specimen
obtain
studi
particip
regular
basi
regardless
presenc
absenc
symptom
studi
stand
virtu
intens
virolog
clinic
surveil
undertaken
total
individu
household
univers
utah
campu
commun
provid
symptom
diari
selfcollect
anterior
nasal
swab
sampl
weekli
consecut
week
diari
also
includ
inform
absenc
work
school
medic
visit
credit
investig
team
diari
specimen
avail
analysi
episod
week
character
regard
occurr
ill
base
symptom
diari
presenc
absenc
respiratori
virus
measur
molecular
test
ill
episod
defin
continu
period
presenc
symptom
viru
episod
defin
continu
period
detect
viru
studi
signific
strength
describ
also
limit
number
household
particip
rel
small
addit
studi
confin
singl
commun
singl
year
particip
recruit
univers
commun
studi
popul
probabl
educ
higher
socioeconom
stratum
gener
us
popul
molecular
test
development
version
filmarray
respiratori
panel
multiplex
respiratori
panel
perform
characterist
test
version
provid
factor
suggest
caution
gener
result
find
furthermor
molecular
detect
viral
nucleic
acid
conclus
proof
activ
infect
caveat
mind
studi
nevertheless
provid
highli
use
inform
molecular
detect
rapidli
becom
major
method
use
detect
respiratori
virus
clinic
set
biglov
provid
data
help
clinician
interpret
result
current
molecular
assay
like
previou
studi
biglov
document
impress
frequenc
respiratori
symptom
infect
respiratori
virus
present
commun
given
time
respiratori
symptom
present
personweek
children
age
year
personweek
older
children
adult
particip
experienc
mean
respiratori
ill
episod
per
year
children
age
year
sixti
percent
respiratori
ill
episod
associ
detect
virus
interestingli
virusposit
episod
like
associ
miss
school
andor
work
virusneg
episod
ill
occur
rel
mild
requir
emerg
depart
visit
hospit
virus
detect
personweek
children
age
year
children
year
adult
viru
episod
common
virus
rhinoviru
bocaviru
coronaviru
strikingli
virus
present
virusposit
week
rhinoviru
detect
least
studi
particip
highli
pathogen
virus
much
less
common
influenza
respiratori
syncyti
viru
account
episod
respect
fiftysix
percent
virusposit
episod
rhinovirusposit
episod
associ
symptom
mean
asymptomat
virus
proport
episod
symptomat
rang
human
metapneumoviru
bocaviru
use
data
biglov
relat
durat
polymeras
chain
reaction
pcr
posit
virusposit
episod
overal
virusposit
episod
pcr
posit
less
week
mean
durat
posit
week
among
episod
posit
week
longer
account
rhinoviru
bocaviru
rhinovirusposit
episod
mean
durat
pcr
posit
less
week
episod
posit
week
longer
likewis
bocaviru
mean
durat
posit
less
week
episod
remain
posit
week
limit
analysi
sinc
rhinovirus
type
possibl
distinguish
continu
posit
singl
infect
vs
close
space
infect
differ
rhinoviru
type
recent
report
loeffelholz
et
al
episod
rhinoviru
posit
infant
age
year
actual
consecut
infect
differ
rhinoviru
type
base
find
biglov
author
conclud
prolong
pcr
posit
acut
respiratori
infect
may
confound
interpret
posit
pcr
test
thu
find
biglov
illustr
fundament
limit
pathogenbas
diagnosi
name
detect
pathogen
prove
caus
patient
ill
discuss
distinguish
bacteri
colon
activ
infect
new
recent
introduct
sensit
molecular
test
respiratori
gastrointestin
virus
ad
viral
dimens
discuss
regard
rhinoviru
especi
problemat
viru
increasingli
respect
legitim
respiratori
pathogen
caus
lower
airway
well
upper
airway
diseas
also
detect
frequent
asymptomat
young
children
clinician
receiv
report
patient
posit
rhinoviru
frequent
perplex
signific
find
given
high
background
rate
pcr
posit
asymptomat
individu
clinician
may
convinc
rhinoviru
caus
patient
ill
may
feel
compel
prescrib
antibiot
case
bacteri
coinfect
appeal
approach
escap
conundrum
queri
host
respons
effort
go
beyond
tradit
biomark
creactiv
protein
procalcitonin
sever
group
investig
host
gene
express
peripher
blood
leukocyt
shown
differ
respons
viral
vs
bacteri
infect
respons
symptomat
vs
asymptomat
infect
proteom
metabolom
provid
altern
path
evalu
host
respons
approach
combin
pathogen
detect
character
host
respons
may
get
us
closer
ultim
goal
test
set
test
inform
clinician
regard
need
antibiot
therapi
capabl
would
empow
clinician
withhold
antibiot
bacteri
infect
unlik
would
key
lessen
current
overus
antibiot
treat
viral
respiratori
infect
